Literature DB >> 15205365

Anthony Dipple Carcinogenesis Award. p53 from pathway to therapy.

David Lane1.   

Abstract

In the 25 years since its first description the p53 protein has been shown to play a key role in both tumour suppression and aging. New discoveries about the function and control of p53 continue to emerge every month and attempts to exploit the system to develop better therapeutics and diagnostics are beginning to be successful in the clinic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15205365     DOI: 10.1093/carcin/bgh186

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.

Authors:  Lorna Jane Warnock; Sally Anne Raines; Jo Milner
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

2.  RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Authors:  Mohd Feroz Mohd Omar; Kosei Ito; Min En Nga; Ross Soo; Bee Keow Peh; Tuty Muliana Ismail; Bhavin Thakkar; Richie Soong; Yoshiaki Ito; Manuel Salto-Tellez
Journal:  Pathol Oncol Res       Date:  2012-06-24       Impact factor: 3.201

3.  Redundancy of DNA helicases in p53-mediated apoptosis.

Authors:  E A Spillare; X W Wang; C von Kobbe; V A Bohr; I D Hickson; C C Harris
Journal:  Oncogene       Date:  2006-03-30       Impact factor: 9.867

4.  Allelic loss at TP53 in metastatic human endometrial carcinomas.

Authors:  Wiktor Szewczuk; Danuta Skomra; Marek Cybulski; Dorota Przadka-Rabaniuk; Agata Filip; Maciej Jóźwik; Piotr Olcha; Albert Roessner; Andrzej Semczuk
Journal:  Clin Exp Metastasis       Date:  2009-06-30       Impact factor: 5.150

Review 5.  The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.

Authors:  Qian Qiao; Weiguo Hu
Journal:  Lung       Date:  2013-04-18       Impact factor: 2.584

6.  No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis.

Authors:  Raju K Mandal; Suraj S Yadav; Aditya K Panda
Journal:  Tumour Biol       Date:  2014-05-28

Review 7.  The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review.

Authors:  Andrzej Semczuk; Marek Gogacz; Anna Semczuk-Sikora; Maciej Jóźwik; Tomasz Rechberger
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

Review 8.  Model of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes.

Authors:  Shian-Ling Ding; Chen-Yang Shen
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

9.  Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway.

Authors:  Shadia Al-Bahlani; Ikram A Burney; Buthaina Al-Dhahli; Safiya Al-Kharusi; Fakhra Al-Kharousi; Amani Al-Kalbani; Ikhlas Ahmed
Journal:  BMC Pharmacol Toxicol       Date:  2020-09-01       Impact factor: 2.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.